<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report overexpression of the proto-oncogene bcl-2 in gastrointestinal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and its precursor lesions </plain></SENT>
<SENT sid="1" pm="."><plain>The bcl-2 proto-oncogene is centrally involved in the <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> of human follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> via a chromosomal translocation t(14;18)(q32;q21) and is also expressed in the epithelial regenerative compartment or the basal crypts of the <z:mpath ids='MPATH_458'>normal</z:mpath> colon and small intestine </plain></SENT>
<SENT sid="2" pm="."><plain>We describe an immunohistochemical analysis of fixed, paraffin-embedded tissue using both a polyclonal rabbit and a monoclonal mouse antibody to the Bcl-2 protein </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to confirming bcl-2 expression in <z:mpath ids='MPATH_458'>normal</z:mpath> colonic and small intestinal crypts, we also observed expression in the gastric epithelial regenerative compartment, the mucous neck region </plain></SENT>
<SENT sid="4" pm="."><plain>No increased expression was found in nonneoplastic or inflammatory <z:e sem="disease" ids="C0947761" disease_type="Disease or Syndrome" abbrv="">gastrointestinal conditions</z:e>, including <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, or inflammatory or <z:hpo ids='HP_0004390'>hamartomatous polyps</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Increased bcl-2 expression, however, was present in hyperplastic <z:mp ids='MP_0003269'>colonic polyps</z:mp> and in the majority of dysplastic lesions, from the earliest precursors through large <z:mpath ids='MPATH_270'>adenomas</z:mpath>, high grade flat <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0000001'>all</z:hpo> in comparison with adjacent internal control <z:mpath ids='MPATH_458'>normal</z:mpath> epithelium </plain></SENT>
<SENT sid="6" pm="."><plain>Increased expression was present in dysplastic glandular lesions from <z:hpo ids='HP_0000001'>all</z:hpo> gastrointestinal sites, including colon, small bowel, and stomach </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, bcl-2 expression was frequently abnormal in nondysplastic epithelium surrounding dysplastic lesions, suggesting that altered expression occurred before the development of morphological <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Specifically, directly contiguous morphologically nondysplastic epithelium often showed abnormal bcl-2 expression throughout the full length of the crypt-villus axis </plain></SENT>
<SENT sid="9" pm="."><plain>This expression pattern gradually diminished to involve only the crypt base (the <z:mpath ids='MPATH_458'>normal</z:mpath> pattern of expression), proceeding away from malignant or dysplastic lesions </plain></SENT>
<SENT sid="10" pm="."><plain>Abnormal bcl-2 immunoreactivity in 1), the earliest precursor dysplastic lesions and its persistence throughout <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> and 2), contiguous morphologically unaltered nondysplastic epithelium suggests that bcl-2 alterations occur early during the morphological and molecular sequence of events leading to gastrointestinal epithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>